Diagnostic value of Tc-99m sestamibi gated SPECT to assess viability in a patient after acute myocardial infarction

Clinical Nuclear Medicine

Volumn 21, Issue 1, 1996, Pages 19-23

  Hambye, Anne Sophie ^a   Van Den Branden, Frank ^a   Vandevivere, Johan ^a  

^a MIDDELHEIM HOSPITAL   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

METHOXY ISOBUTYL ISONITRILE TECHNETIUM TC 99M; THALLIUM 201;

ACUTE HEART INFARCTION; ADULT; ANGIOCARDIOGRAPHY; ARTICLE; CASE REPORT; CONTROLLED STUDY; CORONARY ARTERY OBSTRUCTION; DIAGNOSTIC VALUE; EXERCISE TEST; FEMALE; GATED IMAGING; HEART LEFT VENTRICLE FUNCTION; HEART MUSCLE ISCHEMIA; HUMAN; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY;

FEMALE; HUMANS; MIDDLE AGED; MYOCARDIAL INFARCTION; TECHNETIUM TC 99M SESTAMIBI; TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON; VENTRICULAR FUNCTION, LEFT;

EID: 0030064109     PISSN: 03639762     EISSN: None     Source Type: Journal    
DOI: 10.1097/00003072-199601000-00006     Document Type: Article

References (24)

1. Maseri A: Viable but noncontractile myocardium: The clinical problem. J Nucl Cardiol 1:S31, 1994.
2. Gimple LW, Beller GA: Assessing prognosis after acute myocardial infarction in the thrombolytic era. J Nucl Cardiol 2:198, 1994.
3. Tillisch J, Brunken R, Marshall R, et al: Reversibility of cardiac wall motion abnormalities predicted by positron tomography. N Engl J Med 314:884, 1986.
4. Schelbert HR: Metabolic imaging to assess myocardial viability. J Nucl Med 35:S8, 1994.
5. Rocco TP, Dilsizian V, McKusick KA, et al: Comparison of Thallium redistribution with rest "reinjection" imaging for the detection of viable myocardium. Am J Cardiol 66:158, 1990.
6. Beanlands RS, Dawood F, Wen W-H, et al: Are the kinetics of Technetium-99m methoxyisobutyl isonitrile affected by cell metabolism and viability ? Circulation 82:1802, 1990.
7. Piwnica-Worms D, Kronauge JF, Chiu ML: Uptake and retention of hexakis (2-methoxyisobutyl isonitrile) Technetium (I) in cultured chick myocardial cells. Mitochondrial and plasma membrane potential dependence. Circulation 82:1826, 1990.
8. Rigo P, Benoit T, Braat S: The role of 99mTc sestamibi in the evaluation of myocardial viability. Nijhoff M (ed), Dialogues in Nuclear Cardiology. Dordrecht, Kluwer Academic Publishers, 1994, pp 1-20.
9. Dobbeleir A, Franken PR, Vandevivere J: A normalisation method for quantification of myocardial perfusion images independant of normal tissue localisation. (abstr) Eur J Nucl Med 18:660, 1991.
10. Grucker D, Florentz P, Oswald T, et al: Myocardial gated tomoscintigraphy with 99Tcm-methoxy-isobutyl-isonitrile (MIBI): Regional and temporal activity curve analysis. Nucl Med Commun 10:723, 1989.
11. Marcassa C, Marzullo P, Parodi O, et al: A new method for noninvasive quantitation of segmental myocardial wall thickening using Technetium-99m 2-methoxy-isobutyl-isonitrile scintigraphy. Results in normal subjects. J Nucl Med 31:173, 1990.
12. Verzijlbergen JF, Suttorp MJ, Ascoop CA, et al: Combined assessment of technetium-99m SESTAmIBI planar myocardial perfusion imaging at rest and during exercise with rest/exercise left ventricular wall motion studies evaluated from gated myocardial perfusion studies. Am Heart J 123:59, 1992.
13. Mochizuki T, Murase K, Fujiwara Y, et al: Assessment of systolic thickening with Thallium-201 ECG-gated single-photon emission computed tomography: A parameter for local left ventricular function. J Nucl Med 32:1496, 1991.
14. Hoffman EJ, Huang SC, Phelps ME: Quantitation in positron emission computed tomography: I. Effect of object size. J Comput Assist Tomogr 8:1083, 1984.
15. Goris ML, Thompson C, Malone LJ, et al: Modelling the integration of myocardial regional perfusion and function. Nucl Med Commun 15:9, 1994.
16. Chua T, Kiat H, Germano G, et al: Gated Technetium-99m Sestamibi for simultaneous assessment of stress myocardial perfusion, postexercise regional ventricular function and myocardial viability. J Am Coll Cardiol 23:1107, 1994.
17. DePuey EG, Rozanski A: Gated Tc-99m Sestamibi SPECT to characterize fixed defects as infarct or artifact. (abstr) J Nucl Med 33:927, 1992.
18. Iskandrian AS, Schelbert HR: Introduction. In Myocardial viability assessment. J Nucl Med 35:S1, 1994.
19. Franken PR, De Geeter F, Dendale P, et al: Regional distribution of 1231-(ortho-iodophenyl)-pentadecanoic acid and 99Tcm-MIBI in relation to wall motion after thrombolysis for acute myocardial infarction. Nucl Med Commun 14:310, 1993.
20. Murray GL, Schad NC, Magil HL, et al: Myocardial viability assessment with dynamic low-dose iodine-123-lodophenylpentadecanoic acid metabolic imaging: Comparison with myocardial biopsy and reinjection SPECT Thallium after myocardial infarction. J Nucl Med 35:S43-48, 1994.
21. Cuocolo A, Pace L, Ricciardelli B, et al: Identification of viable myocardium in patients with chronic coronary artery disease: Comparison of Thallium-201 scintigraphy with reinjection and Technetium-99m-methoxyisobutyl isonitrile. J Nucl Med 33:505, 1992.
22. Dilsizian V, Arrighi JA, Diodati JG, et al: Myocardial viability in patients with chronic coronary artery disease. Comparison of m99Tc-Sestamibi with Thallium reinjection and [18F]Fluorodeoxyglucose. Circulation 89:578, 1994.
23. Maurea S, Cuocolo A, Pace L, et al: Rest-injected Thallium-201 redistribution and resting Technetium-99m methoxyisobutyl-isonitrile uptake in coronary artery disease: Relation to the severity of coronary artery stenosis. Eur J Nucl Med 20:502, 1993.
24. Mannting F, Morgan-Mannting MG: Gated SPECT with Technetium-99m-Sestamibi for assessment of myocardial perfusion abnormalities. J Nucl Med 34:601, 1993.